This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CONMED Corporation Q2 2010 Earnings Call Transcript

CONMED Corporation (CNMD)

Q2 2010 Earnings Call

July 29, 2010 10:00 am ET

Executives

Joe Corasanti - President and CEO

Rob Shallish - CFO

Analyst s

Matt Miksic - Piper Jaffray

Dalton Chandler - Needham & Company

James Sidoti - Sidoti & Company

Robert Goldman - CL King

Valerie Brown - Alliance Bernstein

Presentation

Operator

Good day ladies and gentlemen and welcome to the second quarter 2010 CONMED earnings conference call. My name is Louisa and I will be your operator for today. (Operator Instructions) As a reminder this conference is being recorded for replay purposes. I would now like to turn the call over to Mr. Joe Corasanti, President and CEO of CONMED. Please proceed, sir.

Joe Corasanti

Thank you very much. Good morning everyone. Welcome to CONMED Corporation's second quarter 2010 earnings conference call. With me today is Rob Shallish, our Chief Financial Officer. After formal remarks the call will be opened for questions.

Before we begin, let me remind you that during this call we will be making comments and statements regarding our financial outlook, which represents forward-looking statements that involve risks and uncertainties as those terms are defined under the Federal Securities laws.

Our actual results may differ materially from our current expectations. Please refer to the risk factors and other cautionary factors in today's press release, as well as our SEC filings for more details on factors that may cause actual results to differ materially.

You will also hear Rob and me refer to certain non-GAAP measurements during this discussion. While these figures are not a substitute for GAAP measurements, company management uses them to aid us in monitoring the company's ongoing financial performance from quarter-to-quarter and year-to-year on a regular basis and for benchmarking against other medical technology companies.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
CNMD $51.37 2.40%
AAPL $128.64 -0.24%
FB $78.68 -0.39%
GOOG $541.17 0.61%
TSLA $229.95 1.70%

Markets

DOW 18,072.13 +48.07 0.27%
S&P 500 2,115.02 +6.73 0.32%
NASDAQ 5,021.9070 +16.5160 0.33%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs